title: [Obstruction of the upper airways in humans and animal models].
abstract: Obstructive sleep apnea (OSA) is caused by repetitive collapse of a narrow upper airway during sleep with the main risk factor being obesity. Apneas are followed by hypoxia, sympathetic activation, intrathoracic pressure swings and arousals. In most animal studies, only the cyclical pattern of hypoxia characteristic of OSA is simulated, however, more complex models have also been developed which additionally reflect the other pathophysiological changes associated with sleep-disordered breathing. These models have contributed to a deeper understanding of the cardiovascular and metabolic consequences of OSA. From other experiments the concept of the pharynx behaving like a collapsible tube, i. e. a Starling resistor, has emerged. Finally, the neurotransmitter modulation of upper airway muscle tone has been elucidated by using IN VIVO microdialysis of the caudal medulla of rats. It is hoped that findings from animal studies will in the future impact on the management of patients with OSA, in particular if they are non-compliant with CPAP therapy.
authors.affiliation: Universitätsklinik Giessen und Marburg, Medizinische Klinik II, Schlafmedizinisches Labor, Giessen. Richard.Schulz@innere.med.uni-giessen.de
authors.forename: R
authors.initials: R
authors.lastname: Schulz
mesh_terms: D000818:Animals; D001143:Arousal / Q000502:physiology; D004195:Disease Models, Animal; D006801:Humans; D000860:Hypoxia / Q000503:physiopathology; D008526:Medulla Oblongata / Q000503:physiopathology; D051379:Mice; D009129:Muscle Tonus / Q000502:physiology; D018377:Neurotransmitter Agents / Q000378:metabolism; D009765:Obesity / Q000150:complications / Q000503:physiopathology; D010614:Pharynx / Q000503:physiopathology; D012123:Pulmonary Ventilation / Q000502:physiology; D051381:Rats; D012132:Respiratory Muscles / Q000503:physiopathology; D020181:Sleep Apnea, Obstructive / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000503:physiopathology
chemical_list: D018377:Neurotransmitter Agents